agilon health, inc. (NYSE:AGL - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Thursday after Citigroup lowered their price target on the stock from $2.50 to $1.75. Citigroup currently has a sell rating on the stock. agilon health traded as low as $1.75 and last traded at $1.77, with a volume of 249680 shares trading hands. The stock had previously closed at $1.88.
Several other brokerages also recently commented on AGL. Stifel Nicolaus reduced their price target on shares of agilon health from $7.00 to $2.00 and set a "hold" rating for the company in a research report on Tuesday. Barclays reduced their price target on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a research report on Monday. Benchmark restated a "buy" rating and issued a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Bank of America downgraded shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target for the company. in a research report on Wednesday, October 2nd. Finally, William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a research report on Friday, November 8th. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $6.38.
Get Our Latest Research Report on AGL
Insider Activity
In other agilon health news, CEO Steven Sell purchased 20,000 shares of the business's stock in a transaction dated Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company's stock, valued at $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 3.20% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in agilon health by 6.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 640,048 shares of the company's stock valued at $2,515,000 after buying an additional 37,725 shares during the last quarter. MetLife Investment Management LLC grew its stake in agilon health by 114.8% in the 3rd quarter. MetLife Investment Management LLC now owns 167,789 shares of the company's stock valued at $659,000 after buying an additional 89,675 shares during the last quarter. Quantbot Technologies LP acquired a new position in agilon health in the 3rd quarter valued at $1,742,000. Dynamic Technology Lab Private Ltd acquired a new position in agilon health in the 3rd quarter valued at $171,000. Finally, Algert Global LLC grew its stake in agilon health by 80.2% in the 3rd quarter. Algert Global LLC now owns 184,530 shares of the company's stock valued at $725,000 after buying an additional 82,123 shares during the last quarter.
agilon health Stock Down 8.5 %
The business's 50 day moving average is $3.14 and its 200-day moving average is $4.90. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $708.67 million, a price-to-earnings ratio of -2.01 and a beta of 0.60.
agilon health (NYSE:AGL - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the business posted ($0.06) earnings per share. Equities analysts anticipate that agilon health, inc. will post -0.35 EPS for the current fiscal year.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
